Response to Comment on “Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin”

被引：0
|
作者：
Morganne Sindelar
Daniel McCabe
Elisabeth Carroll
机构：
[1] The University of Iowa Hospitals & Clinics,Division of Medical Toxicology, Department of Emergency Medicine
[2] The University of Iowa Hospitals & Clinics,undefined
来源：
Journal of Medical Toxicology | 2023年 / 19卷
关键词：
Drug-drug interaction; Tacrolimus; Nirmatrelvir/ritonavir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：309 / 309
相关论文
共 50 条
  • [21] Nirmatrelvir/ritonavir drug-drug interactions in primary care outpatients
    Esquiroz, Andrea Rodriguez
    Alvarez, Lorea Sanz
    Marin, Marta Marin
    Gonzalez, Patricia Garcia
    Cobos, Paula Aldave
    Parra, Javier Garjon
    ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2023, 46 (03)
  • [22] Overview of Drug-Drug Interactions Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Targeted Therapy and Supportive Care for Lung Cancer
    Anwar, Kaleem
    Nguyen, Lee
    Nagasaka, Misako
    Ou, Sai-Hong Ignatius
    Chan, Alexandre
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (02):
  • [23] Drug-drug interaction of Nirmatrelvir/ritonavir and tacrolimus: A potential risk disproportionality analysis of nephrotoxicity from COVID-19 reports in FAERS
    Qin, Fuhong
    Wang, Huiling
    Li, Meng
    Zhuo, Shengnan
    Liu, Wei
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (12) : 1321 - 1327
  • [24] Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir/ritonavir) administration in a kidney transplant recipient
    Kwon, Eun-Jeong
    Gi-AeYun
    Park, Seokwoo
    Kim, Sejoong
    Chae, Dong-Wan
    Park, Hyung Sub
    Lee, Taeseung
    Jeong, Jong Cheol
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2022, 41 (06) : 768 - 770
  • [25] Safely Prescribing Nirmatrelvir and Ritonavir-Avoiding Drug-Drug Interactions
    Culas, Roshni
    Nath, Sridesh
    Nath, Sarath
    JAMA INTERNAL MEDICINE, 2023, 183 (04) : 362 - 363
  • [26] A model-based pharmacokinetic assessment of drug-drug interaction between tacrolimus and nirmatrelvir/ritonavir in a kidney transplant patient with COVID-19
    Tomida, Takeshi
    Itohara, Kotaro
    Yamamoto, Kazuhiro
    Kimura, Takeshi
    Fujita, Kohei
    Uda, Atsushi
    Kitahiro, Yumi
    Yokoyama, Naoki
    Hyodo, Yoji
    Omura, Tomohiro
    Yano, Ikuko
    DRUG METABOLISM AND PHARMACOKINETICS, 2023, 53
  • [27] Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions
    Marzolini, Catia
    Kuritzkes, Daniel R.
    Marra, Fiona
    Boyle, Alison
    Gibbons, Sara
    Flexner, Charles
    Pozniak, Anton
    Boffito, Marta
    Waters, Laura
    Burger, David
    Back, David
    Khoo, Saye
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (05) : 744 - +
  • [28] Drug-drug interactions and dose management of BTK inhibitors when initiating nirmatrelvir/ritonavir (paxlovid) based on physiologically-based pharmacokinetic models
    Li, Chao
    Chen, Lu
    Li, Lixian
    Chen, Wanyi
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 189
  • [29] Acute tacrolimus toxicity due to concomitant use of ritonavir (with nirmatrelvir as Paxlovid)
    Browne, Evan
    White, Cameron
    Darley, David
    Murnion, Bridin
    AUSTRALIAN PRESCRIBER, 2024, 47 (06) : 192 - 193
  • [30] Nirmatrelvir/ritonavir treatment of patients with COVID-19 taking tacrolimus: case series describing the results of drug-drug interactions
    Shen, Dan
    Gong, Yinhua
    Qian, Yulan
    Zhu, Jianguo
    Gao, Jie
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (05)
12345